chr17-27309105-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015626.10(WSB1):āc.717C>Gā(p.Phe239Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000125 in 1,594,624 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015626.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WSB1 | NM_015626.10 | c.717C>G | p.Phe239Leu | missense_variant | 6/9 | ENST00000262394.7 | NP_056441.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WSB1 | ENST00000262394.7 | c.717C>G | p.Phe239Leu | missense_variant | 6/9 | 1 | NM_015626.10 | ENSP00000262394 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152072Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000822 AC: 2AN: 243224Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 131642
GnomAD4 exome AF: 6.93e-7 AC: 1AN: 1442434Hom.: 0 Cov.: 31 AF XY: 0.00000140 AC XY: 1AN XY: 716270
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152190Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74404
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2024 | The c.717C>G (p.F239L) alteration is located in exon 6 (coding exon 6) of the WSB1 gene. This alteration results from a C to G substitution at nucleotide position 717, causing the phenylalanine (F) at amino acid position 239 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at